moxibustion
Search documents
Charming Medical Limited Announces Full Exercise of Representative's Over-allotment Option
Prnewswire· 2025-10-28 20:15
Core Viewpoint - Charming Medical Limited, a Hong Kong-based provider of Traditional Chinese Medicine (TCM)-inspired therapies, has successfully completed its initial public offering (IPO) and has raised approximately $7.36 million in gross proceeds from the offering, including an over-allotment option exercised by underwriters [1][2]. Company Overview - Charming Medical Limited integrates TCM principles with modern technology to enhance quality of life and promote holistic well-being. The company operates four wellness centers in Hong Kong, offering services such as womb-warming therapy, pelvic detox therapy, moxibustion, prenatal massage, and traditional abdominal binding, focusing on women's health issues [6]. - Under the "Beauty Lab" brand, the company develops and distributes TCM-inspired supplements and beauty products aimed at improving women's constitution and vitality. These products include uterine care patches, probiotic washes, and nourishing herbal formulations [6]. - The company also provides technical training, dietary therapy consultancy, and franchise opportunities to extend its wellness philosophy to other practitioners and entrepreneurs [6]. Offering Details - The IPO consisted of 1,600,000 Class A ordinary shares priced at $4.00 per share, with an additional 240,000 shares purchased through the over-allotment option, resulting in gross proceeds of $0.96 million from the over-allotment [1][2]. - The offering was conducted on a firm commitment basis, with Cathay Securities, Inc. acting as the representative of the underwriters [3]. - The registration statement for the offering was filed with the SEC and declared effective on September 30, 2025, with a final prospectus available on the SEC's website [4].
Charming Medical Limited Announces Closing of Initial Public Offering
Prnewswire· 2025-10-22 16:51
Core Viewpoint - Charming Medical Limited has successfully completed its initial public offering (IPO) on the Nasdaq Capital Market, raising a total of $6.4 million from the sale of 1,600,000 Class A ordinary shares at a price of $4.00 per share [1][2]. Group 1: Offering Details - The IPO consisted of 1,600,000 Class A ordinary shares priced at $4.00 each, with trading commencing on October 21, 2025 [1]. - The total gross proceeds from the offering amount to $6.4 million, which will be utilized for business expansion, strategic investments, research and development, and general corporate purposes [2]. - An over-allotment option has been granted to underwriters for an additional 240,000 shares, which could increase gross proceeds to approximately $7.36 million if fully exercised [3]. Group 2: Company Background - Charming Medical Limited is a Hong Kong-based provider of Traditional Chinese Medicine (TCM)-inspired therapies and products, integrating TCM principles with modern technology [7]. - The company operates four wellness centers in Hong Kong, offering services aimed at addressing women's health issues, including womb-warming therapy and prenatal massage [7]. - Under the "Beauty Lab" brand, the company develops TCM-inspired supplements and beauty products, focusing on improving women's health and vitality [7].
Visionary Completes Controlling Stake in Sikang Health Industry Joint Venture Platform, Deepening Global Layout of TCM Health Preservation
Prnewswire· 2025-10-17 13:30
Core Insights - Visionary Holdings Inc. has completed an equity adjustment to acquire a 51% stake in Sikang (Guangzhou) Health Industry Investment Co., Ltd., marking a significant step in its strategy for global high-quality industry investment [1][3] Group 1: Strategic Synergy and Business Model - The joint venture with Guangzhou Sikang aims to leverage capital and industrial resources to enhance standardized services and global expansion in the Traditional Chinese Medicine (TCM) health preservation sector [1][3] - Guangzhou Sikang has established an industrial ecosystem focused on professional talent education, brand chain expansion, and intelligent resource trading, creating a mature operational model for TCM health services [2][3] Group 2: Business Development and Market Expansion - Prior to the equity adjustment, Guangzhou Sikang made progress in both domestic operations and international exploration, including an initial expansion into the Southeast Asian market with TCM products and services [4] - The company held a TCM Health Preservation Ecosystem Cooperation Conference, gathering over 200 partners to enhance domestic channel cooperation and service standardization [4] Group 3: Long-term Value and Shareholder Returns - Visionary's management emphasizes the long-term growth potential of TCM health preservation, aligning with its strategy to create sustainable shareholder value [5][6] - The company plans to empower the joint venture by providing compliant capital support, connecting global industrial channels, and integrating technologies to promote service standardization [6]